Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | GRI |
Description | GRI Bio, Inc. and Vallon Pharmaceuticals Complete GRI Bio is a development stage biotech treating inflammatory, fibrotic and autoimmune disorders by regulating NKT cells to reset dysfunctional immune responses. We are initally focused on IPF and |
Keywords | GRI Bio, NKT, natural killer T cells, IPF, fibrosis |
WebSite | gribio.com |
Host IP | 69.195.112.203 |
Location | United States |
Site | Rank |
US$1,911
Last updated: 2023-05-18 01:15:58
gribio.com has Semrush global rank of 0. gribio.com has an estimated worth of US$ 1,911, based on its estimated Ads revenue. gribio.com receives approximately 220 unique visitors each day. Its web server is located in United States, with IP address 69.195.112.203. According to SiteAdvisor, gribio.com is safe to visit. |
Purchase/Sale Value | US$1,911 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$52 |
Yearly Ads Revenue | US$635 |
Daily Unique Visitors | 14 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
gribio.com. | A | 7199 | IP: 69.195.112.203 |
gribio.com. | NS | 21600 | NS Record: ns2.justhost.com. |
gribio.com. | NS | 21600 | NS Record: ns1.justhost.com. |
gribio.com. | MX | 14400 | MX Record: 5 alt1.aspmx.l.google.com. |
gribio.com. | MX | 14400 | MX Record: 5 alt2.aspmx.l.google.com. |
gribio.com. | MX | 14400 | MX Record: 1 aspmx.l.google.com. |
gribio.com. | MX | 14400 | MX Record: 10 aspmx2.googlemail.com. |
gribio.com. | MX | 14400 | MX Record: 10 aspmx3.googlemail.com. |
gribio.com. | MX | 14400 | MX Record: 20 mail.gribio.com. |
gribio.com. | TXT | 14400 | TXT Record: v=spf1 +a +mx +ip4:173.254.30.244 +ip4:69.195.112.203 +include:_spf.google.com ~all |
gribio.com. | TXT | 14400 | TXT Record: v=spf1 +a +mx +ip4:173.254.30.244 +ip4:69.195.112.203 +include:justhost.com ~all |
GRI Bio GRI BIO GRI BIO SCIENCE PROGRAMS TEAM NEWS INVESTORS GRI Bio, Inc. and Vallon Pharmaceuticals Complete Merger Click to read the press release Advancing Innovative Pipeline of NKT Cell Modulators for the Treatment of High-Value Inflammatory, Fibrotic and Autoimmune Diseases GRI Bio is a clinical stage biotech company focused on fundamentally changing the way inflammatory disease is treated by targeting NKT immune cells earlier in the inflammatory chain to interrupt disease progression more effectively. GRI Bio’s lead program, GRI-0621, is a small molecule RAR-βɣ dual agonist that inhibits the activity of human Type 1 invariant NKT (iNKT) cells, returning the immune system to homeostasis. Oral dosing of GRI-0621 has been shown to inhibit iNKT cells in patients and improve fibrosis in multiple disease models. GRI Bio is planning to launch a Phase 2a biomarker study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) with data expected in 2024. GRI Bio’s |
HTTP/1.1 200 OK Date: Wed, 04 May 2022 08:26:33 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Last-Modified: Fri, 09 Oct 2020 19:54:17 GMT Accept-Ranges: bytes Content-Length: 4635 Vary: Accept-Encoding Content-Type: text/html |
Domain Name: GRIBIO.COM Registry Domain ID: 1798208252_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2022-04-17T18:40:38Z Creation Date: 2013-05-01T21:40:20Z Registry Expiry Date: 2023-05-01T21:40:20Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.JUSTHOST.COM Name Server: NS2.JUSTHOST.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-04T09:13:24Z <<< |